Abbott forecasts in line annual profit on medical device sales
1. Abbott expects demand for glucose-monitoring devices to rise. 2. Annual profit forecast aligns with Wall Street estimates.
1. Abbott expects demand for glucose-monitoring devices to rise. 2. Annual profit forecast aligns with Wall Street estimates.
Abbott's forecast suggests stable growth potential, similar to past performance during increased demand periods.
The article highlights future demand for Abbott products, which can directly influence revenue and stock price.
Short-term profit forecasts can quickly influence investor sentiment and stock performance.